Date : 18/11/2025

On Tuesday 18/11/2025 the SDC completed the process of registering the share capital increase of (11,718,750) shares of the Jordanian Pharmaceutical Manufacturing Company.

The share capital increase is performed through capitalization and allocating part of the company’s debt to the main debtor shareholder “Dr. Abdel Jabbar Al-Kubaisi”, provided that these shares are under lock-up for one year from the completion date of the issuance procedures at the Jordan Securities Commission (JSC).

Thereby, the SDC records of the Jordanian Pharmaceutical Manufacturing Company indicates the raise of its capital from (33,698,090) shares to a registered capital of (45,416,840) shares as a result of the mentioned share capital increase.

The above-mentioned procedure is conducted based upon the company's General Assembly's resolution made in its extraordinary meeting held on 15/10/2025 which was granted the approval of the Ministry of Industry, Trade, and Supply on 16/10/2025, and upon the approval of the JSC on the share capital increase issued on 06/11/2025.